We are live on ! Find out more
SGRX

SANGRIX INC. Class A Ordinary Shares

5 hedge funds and large institutions have $25.2K invested in SANGRIX INC. Class A Ordinary Shares in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

25% more funds holding

Funds holding: 45 (+1)

0.01% less ownership

Funds ownership: 0.01%0.01% (-0.01%)

60% less capital invested

Capital invested by funds: $63K → $25.2K (-$37.8K)

Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
1
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change

SGRX Hedge Fund Activity: Q2 2025 in Review

5 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in SANGRIX INC. Class A Ordinary Shares (SGRX) for Q2 2025, worth a combined $25.2K — down 60% from $63K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new SGRX positions and 3 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $10.4K. The largest seller was Virtu Financial, exiting entirely with an estimated $41K sold.

  • 5 institutional investors held SANGRIX INC. Class A Ordinary Shares (SGRX) as of Q2 2025, up from 4 in Q1 2025.
  • Funds reported $25.2K of SANGRIX INC. Class A Ordinary Shares stock for Q2 2025, down 60% quarter-over-quarter.
  • 4 funds opened new SANGRIX INC. Class A Ordinary Shares positions in Q2 2025 and 3 closed out, a net change of +1 holder.
  • The largest SANGRIX INC. Class A Ordinary Shares buyer in Q2 2025 was UBS Group, an estimated $10.4K added.
  • The largest SANGRIX INC. Class A Ordinary Shares seller in Q2 2025 was Virtu Financial, an estimated $41K sold.

Based on aggregated 13F filings for Q2 2025.